Micar21

Micar Innovation provide improved structure based in silico screening for the detection of biologically active compounds / discovers new small molecule drugs through drug discovery platform Micar21, we offer a combination of the most advanced approaches currently used ...

In computer-aided drug design (CADD), the ultimate goal is to be able to predict accurately how strongly a potential drug compound will bind to a protein target (i.e., the compound’s binding affinity). Micar21 Drug Discovery platform able to do this, drug discovery to be significantly accelerated, since we would only need to synthesize in the lab those compounds with predicted high affinity for the target of interest (and predicted low affinity for proteins we didn’t want to interfere with).


Home page of this offering   provided by Micar Innovation